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ABSTRACT 
Chemicalization of the modern society has become a topic of debate in the past few 
decades. Especially chemicals that affect the human reproduction and hormonal 
system, the so-called endocrine disrupting compounds, have raised concern in public 
and regulatory agencies. There is a growing need for suitable testing methods to 
screen endocrine disrupting potential of new and old chemicals. While the European 
Union chemical legislation REACH has increased the need of chemical testing 
methods, one of its targets is also to decrease the use of animals in these tests. It has 
been proposed that inexpensive high throughput in vitro assays could be used for initial 
screening of chemicals for further testing with other methods.  
In addition to chemical testing, environmental monitoring of endocrine disrupting 
compounds is important to assess the level of exposure and possible adverse effects 
of chemicals on humans and wildlife. Chemical analysis methods used in 
environmental monitoring are sensitive, but they are also laborious, expensive, and 
require specialized instruments. Consequently, robust biological methods have 
become valuable tools to measure endocrine disrupting potency of chemicals and 
environmental samples. For this purpose, several Saccharomyces cerevisiae yeast 
cell-based bioreporters utilizing different nuclear receptors have been developed. 
Yeast-cell-based bioreporter assays have several advantages in environmental 
analytics. In addition to being inexpensive, they are particularly useful in determining 
the bioavailability of contaminants. Yeast is also very tolerant towards toxicity of 
different sample matrices. Yeast nuclear receptor bioreporter assays have been used 
to determine the total hormonal activity of samples containing unknown mixture of 
chemicals. However, these assays cannot identify the chemicals in the sample, and 
thus, monitoring of a single chemical has not been possible. 
Many cell-based assays have already been adapted to high throughput screening 
plate formats of 384 and 1536 wells and even higher. However, nearly all yeast nuclear 
receptor bioreporter assays are still performed in 96-well plates. Consequently, yeast 
bioreporter assays should be adapted to automated liquid handling and high density 
well plates to enable screening of large chemical libraries and high number of samples. 
In this thesis study, a yeast nuclear receptor bioreporter assay for specific detection 
of a single chemical, bisphenol A (BPA) was developed. The creation of the BPA-
targeted receptor included application of a oligonucleotide-based mutation method and 
a positive-negative genetic selection method for human estrogen receptor α 
(publication I). Chemical specificity of the BPA-targeted receptor (BPA-R) bioreporter 
assay was characterized, and its use demonstrated with chemical mixture and waste 
water samples (publication II). In addition, the existing battery of yeast bioreporters 
was adapted to automated liquid handling and high density 384 and 1536 well plates to 
meet the requirements of high throughput screening (publication III). Finally, a new 
yeast-based bioreporter utilizing a chimeric human retinoid X receptor was constructed 
and characterized (publication IV). This bioreporter can be used to measure organotin 
compounds such as tributyl tin in environmental samples.  
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TIIVISTELMÄ 
Kemikaalit ovat osa modernia maailmaamme. Lähes kaikkien käyttämiemme 
tuotteiden - jopa elintarvikkeiden - valmistuksessa on käytetty erilaisia kemikaaleja 
takaamaan niiden haluttu koostumus, laatu ja turvallisuus. Kemikaalien turvallisuus ja 
ihmisten elinympäristön kemikalisoituminen on kuitenkin herättänyt viime vuosi-
kymmeninä huolta niin suuressa yleisössä kuin viranomaisissakin. Erityisesti 
salakavalalta tuntuvat hormonitoimintaan vaikuttavat kemikaalit ovat huolestuttaneet 
ihmisiä. Näiden ns. hormonihäritsijäkemikaalien on epäilty aiheuttavan mm. 
lisääntymisterveydellisiä, hermostollisia ja aineenvaihdunnan ongelmia. Tällaisia 
kemikaaleja ovat esim. torjunta-aineet, dioksiinit, monet palonestoaineet, muovi-
teollisuuden käyttämät ftalaatit ja bisfenoli A sekä orgaaniset tinayhdisteet. 
Euroopan Unionin kemikaaliasetus REACH tähtää kohti turvallisempaa kemikaalien 
käyttöä. Sen tarkoituksena on laajentaa kemikaalien erilaisten vaikutusten testaamista, 
saattaa testien teettäminen kemikaalien valmistajien vastuulle sekä parantaa käyttö-
turvallisuuden tiedonkulkua kemikaalien tuottajilta niiden käyttäjille. Kemikaalien 
testausvaatimusten lisääntyessä myös uusien testausmenetelmien tarve kasvaa. 
Eläinkokeiden sijaan REACH pyrkii suosimaan tehokkaampia ja eettisempiä 
menetelmiä, kuten in vitro eli ns. ”koeputkessa” tehtäviä solu- ja kudospohjaisia 
määrityksiä. 
Hormonihäiritsijäkemikaalien testauksessa sieniin kuuluva tavallinen leivinhiiva (lat. 
Saccharomyces cerevisiae) on osoittautunut hyväksi työkaluksi. Eläinsoluihin 
verrattuna hiivaa on edullista ja helppoa viljellä ja muokata. Vaikka hiivasoluilta puuttuu 
eläinsolujen tumareseptoreihin perustuva hormonien viestinvälitysketju, tämä ketju 
voidaan saada toimimaan myös hiivassa. Monet ihmisen hormonireseptorit, kuten 
estrogeenireseptori, on onnistuneesti siirretty hiivaan. Kun hiiva altistetaan reseptoriin 
sitoutuvalle kemikaalille, reseptori aktivoituu ja tuottaa solussa ulkoisesti havaittavan 
signaalin. Tätä signaalia mittaamalla voidaan arvioida kemikaalin mahdollista 
vaikutusta kyseiseen hormonireseptoriin ja sen säätelemiin viestinvälitysketjuihin. 
Yksittäisten kemikaalien vaikutusten testaamisen lisäksi hiivasolumenetelmät 
soveltuvat myös erilaisten tuntemattomien ja puhdistamattomien näytteiden 
analysointiin. Tällaisia näytteitä ovat esim. ympäristö- ja vesinäytteet tai vaikkapa 
elintarvikenäytteet. Hiivan avulla voidaan siis seurata ja arvioida ympäristön ja ihmisten 
mahdollista altistumista hormonaalisesti aktiivisille yhdisteille ja niiden seoksille. 
Tässä väitöskirjatyössäni olen vienyt eteenpäin olemassa olevia ja kehittänyt uusia 
hiivasoluihin perustuvia hormonaalisten kemikaalien testausmenetelmiä. Julkaisussa 
(I) suunnittelin menetelmän ihmisen estrogeenireseptorin rakenteen muokkaamiseen, 
ja sovelsin menetelmää kehittääkseni reseptorin, joka aktivoituu vain yhden valitun 
kemikaalin, bisfenoli A:n, sitoutuessa siihen. Julkaisussa (II) tätä muokattua reseptoria 
käytettiin spesifisen bisfenoli A:ta mittaavan hiivamenetelmän kehittämiseen. Tätä 
menetelmää voidaan soveltaa bisfenoli A:n mittaamiseen erilaisissa näytteissä, ja 
arvioimaan altistusta tälle kemikaalille eri lähteistä. Julkaisussa (III) siirsin olemassa 
olevien käsin pipetoitavien hiivamenetelmien käytön perinteisestä 96-kuoppa-
levymittauksesta pipetointirobotin avulla 384- ja 1536-kuoppalevyillä tehtäviin 
määrityksiin. Menetelmä mahdollistaa tehokkaamman analysoinnin ja laajempien 
näytemäärien mittaamisen. Julkaisussa (IV) suunnittelin ja olin mukana toteuttamassa 
uutta hiivamenetelmää, jonka avulla voidaan mitata orgaanisia tinayhdisteitä. 
Menetelmän avulla voidaan mitata ja arvioida tinayhdisteiden biosaatavuutta ja 
sedimentin saastuneisuuden astetta esim. laivaväylillä.  
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1. INTRODUCTION 
1.1. Endocrine disrupting compounds (EDCs) 
In the past few decades, the use of different chemicals in everyday life has 
increased dramatically. After the Second World War chemicals were regarded as 
indicators of development towards better times. In 1962 Rachel Carson shook this 
belief with her book Silent Spring in which a novel type of toxicity of pesticides such as 
DDT on wildlife were described for the first time. Later, when more and more evidence 
on chemicals with special effects on reproduction and development of both humans 
and wildlife started to gather, a group of scientists established the definition of 
endocrine disrupting compounds (EDC) in 1991 (Bern et al. 1992). In a book “Our 
Stolen Future” by Theo Colborn et al. (1997) these compounds were brought to public 
awareness. 
A more recent definition for EDCs by The International Programme on Chemical 
Safety describe them as “an exogenous substance or mixture that alters function(s) of 
the endocrine system and consequently causes adverse effects in an intact organism, 
or its progeny, or (sub)populations.” (Damstra et al. 2002). EDCs have been suspected 
to cause adverse effects such as cancers, embryotoxicity, effects in immune and 
neuronal systems, and impaired reproduction and development in wildlife and humans 
(Damstra et al. 2002, Sharpe & Irvine 2004). In recent years some of these chemicals 
have also been suggested to play a role the in the increasing rates of obesity and 
metabolic syndrome in western world (reviewed by Grün and Blumberg 2007). 
EDCs have been suggested to disrupt the normal functioning of the endocrine 
system in vertebrates primarily via binding to nuclear hormone receptors (NRs). 
Indeed, EDCs share some structural and chemical similarities with natural steroid 
hormones and other small-molecule NR ligands. Well-known EDCs are, for example, 
dioxins, polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons (PAHs), 
some flame retardants, parabens used in cosmetics, organotins such as tributyl tin, 
and plastic ingredients like phthalates and bisphenol A. Some natural ligands of NRs 
and suspected EDCs are shown in Figure 1. 
Bisphenol A (BPA) is a well-known xenoestrogen. It is a high production volume 
chemical with over 1 million tonnes annual production in EU (European Union 2010). It 
is used in numerous products such as polycarbonate plastics, epoxy resins, dental 
sealants, food and beverage packaging, and thermal paper. BPA-containing resins 
have also been used to line water pipes to cut down costs of renovations. 
Biomonitoring studies have shown that humans are constantly exposed to BPA 
(Vandenberg et al. 2010). Although the effects of current BPA exposure levels are still 
controversial there is growing evidence on adverse effects on both humans and wildlife 
(Crain et al. 2007, Flint et al. 2012, Vandenberg et al. 2009, Grün and Blumberg 2007). 
The main exposure routes of BPA for humans occur via food and drink, while 
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environmental BPA emissions are in water phase (European Union 2010). BPA is 
indeed one of the most frequently detected contaminant in water samples (Bono-Blay 
et al. 2012, Loos et al. 2010, Vethaak et al. 2005, Fromme et al. 2002). In order to 
assess the exposure of humans and wildlife to BPA more biomonitoring studies are 
needed (vom Saal et al. 2007). 
 
Figure 1. Structures of some natural ligands of nuclear receptors and suspected 
endocrine disruptors. 
Another example of well characterized EDCs is a group of organic compounds of tin 
(Sn). These chemicals include, for example tributyl tin (TBT) and triphenyl tin (TPT) 
(Figure 1.). TBT is used as an industrial biocide, and until its world-wide ban by 
International Maritime Organization in 2008, it was widely used in antifouling paints in 
ship hulls. Both compounds are persistent and bioaccumulating. Organotin compounds 
can cause, for example, imposex in marine organisms, deterioration of the immune 
system, and impaired reproduction, development, and bone cell differentiation 
(Nishikawa et al. 2004, Titley-O’Neal et al. 2011, Gumy et al. 2008, Sekizawa 1999, 
Yonezawa et al. 2007). Organotin compounds are also suspected to be environmental 
obesogens (Kirchner et al. 2010, Grün & Blumberg 2007). While humans are mostly 
exposed via (sea)food, most of the environmental organotin compounds are found in 
sediments at or close to harbours and shipping channels where their degradation is 
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slow (Sekizawa 1999, Antizar-Ladislao 2008). Concentrations as high as µg g-1 have 
been detected (Antizar-Ladislao 2008), also in Finland (Helminen & Peltonen 2009).  
In 1990's it became evident that vast majority of chemicals used European Union 
(EU) lacked proper safety data, and the current legislation was unable to ensure public 
safety against risks of chemicals (European Commission "White paper" 2001). In order 
to change this situation, and to manage the risks of chemicals in European markets, 
EU launched the new legislation REACH (Registration, Evaluation, Authorization and 
Restriction of CHemicals). Along REACH, a new era in toxicity testing evoked.  
While the existing EU chemical legislation REACH does not require testing 
endocrine disruptive property as an endpoint, the European Commission has 
addressed that there is a need to ensure a proper testing strategy and risk assessment 
for these chemicals. It is clear that there is no comprehensive testing method for 
endocrine disrupting activity of chemicals that could be solely used. Rather, a 
combination of different testing methods should be used. OECD has published a 
framework report for testing endocrine disrupting activity of chemicals (OECD 2012). A 
battery of both in vitro and in vivo methods was suggested. Since one of the aims of 
REACH is to reduce the need of animal tests, robust cell-based assays could be 
suitable first level testing methods. 
In addition to general endocrine disruption activity measurements, there is a need 
for exposure assessment on some existing suspected EDCs, such as bisphenol A 
(BPA). Although chemical analysis methods, such as liquid chromatography (Wille et 
al. 2012) are sensitive, they usually require extensive sample purification, specialized 
instrumentation, and high level technical expertise. They are also poorly suited for high 
throughput screening of a large number of samples. Cell-based bioreporter assays, 
however, are cost-efficient and well suitable for high-throughput screening of both 
environmental and pure chemical samples (Bovee & Pikkemaat 2009, Leskinen et al. 
2005 & 2008). Bioreporters can also measure bioavailability (Hynninen & Virta 2010), 
and the mixture effect of chemicals or total hormonal activity of complex samples 
(Leskinen et al. 2005). 
 
1.2. Yeast–based nuclear receptor bioreporters for EDCs 
Yeast-based nuclear receptor (NR) bioreporter assays have been reviewed before 
in literature (Rajasärkkä & Virta 2013, Bovee & Pikkemaat 2009, Svobodová & 
Cajthaml 2010). The following chapters present a short overview of the currently 
available assays and their suitability to high throughput screening (HTS). 
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1.2.1. Yeast as a nuclear receptor activity study organism 
The common baker’s yeast Saccharomyces cerevisiae is a thoroughly studied and 
well characterized unicellular eukaryotic organism. It is easy to cultivate and there are 
numerous tools available for its genetic manipulation. Due to its similarity with 
mammalian cells, yeast has become a popular organism in studying NR functions and 
ligand affinities. 
NRs are a superfamily of receptors specific to animals. In human genome 48 NRs 
have been found so far. They are divided into three subclasses: type I for steroid 
hormone receptors (e.g. estrogen receptor), type II for other receptors (e.g. thyroid 
receptor), and type III for orphan receptors with no known natural ligand (Jacobs et al. 
2003). NRs function in cells as transcription factors: ligand-bound receptor forms a 
dimer with another receptor, translocates to the cell nucleus, and binds on response 
elements on promoters of genes controlled by the receptor. NRs control numerous 
signaling pathways of, for example, growth, reproduction, and development. 
Many mammalian and yeast-cell-based assays for studying NR activity have been 
developed. Although yeast cells have no endogenous NR signaling pathways, 
functional NRs have been successfully expressed in yeast (Metzger et al. 1988, 
Schena & Yamamoto 1988, Mak et al. 1989, Purvis et al. 1991). The lack of NR-
dependent signaling system in yeast is an advantage since there is no risk of cross-talk 
between the studied and endogenous receptors, whereas this can be the case in 
mammalian cell assays (Bovee et al. 2007, Miller et al. 2010). 
However, yeast and mammalian cell assays have some differences. One of these is 
the ability to distinguish between agonistic, i.e. “receptor activating”, and antagonistic, 
i.e. “receptor repressing” ligands. In natural system in mammalian cells the distinction 
is based on the ligand-activated conformational change of the receptor. Depending on 
the conformation of the NR, and other NRs and cofactors in particular cell type, the 
receptor either activates or represses transcription. Since yeast has no NR cofactor 
proteins, NR-binding ligands show mostly agonistic activity. It has been proposed that 
the higher insensitivity of yeast to antagonists could be an advantage in screening 
hormonal compound because of lower rate of false negatives (Connolly et al. 2011). 
Yet, recent studies have shown that yeast-based NR assays can detect partial or full 
antagonism of chemicals (Michelini et al. 2005, Leskinen et al. 2005, Liu et al. 1999, 
Bovee et al. 2007, Bovee et al. 2010, Kolle et al. 2010). In testing antagonistic effect, 
response of the chemical is measured in the presence of externally added native 
hormone that normally activates the receptor. Thus, the negative effect to transcription 
can be detected (Bovee et al. 2010). The differential response of yeast NR bioreporters 
to antagonists should, however, be considered when testing chemical mixtures and 
complex samples: in principle it is possible that yeast assays would show higher 
activity than mammalian cell assays. 
Differences in metabolic activation or inactivation of a chemical can also result in 
variability between mammalian and yeast cell assays (Beresford et al. 2000, Charles et 
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al. 2000, Hoogenboom et al. 2001). It is possible, however, to incorporate an enzyme-
based metabolic activation step into yeast NR assays (Morohoshi et al. 2005, Rijk et al. 
2008, S. Wang et al. 2010). For example, bovine liver enzyme preparation fraction S9 
is able to convert steroid pro-hormones into active hormones. Using this method the 
predictive value of the bioassay in assessing the potential activity of compounds in vivo 
can be increased. In addition to metabolic effects, other indirect effects that do not 
involve receptor binding, such as enhanced receptor degradation (Wijayaratne & 
McDonnell 2001), are naturally not detected in yeast. 
Mammalian cell NR assays are also usually more sensitive than yeast NR assays 
(Schultis & Metzger 2004, Murk et al. 2002, Svobodová & Cajthaml 2010). It has been 
proposed that yeast cells use transporters to pump out some of the potential NR 
ligands, reducing sensitivity of the assay (Liu et al. 1999, Dudley et al. 2000). By 
removing such transporter from the genome of yeast, sensitivity of a yeast assay can 
be improved (Balsiger et al. 2010). In addition, low permeability of potential NR ligands 
through yeast cell wall can limit sensitivity (Lyttle et al. 1992). However, this effect does 
not seem to harm most of the yeast assays even in short (4-12 hours) incubation time 
(Bovee et al. 2004). It has also been shown that the accuracy of NR yeast assay is 
nearly comparable with mammalian cell assay (Kolle et al. 2010). 
Yeast assays have some advantages over mammalian cell assays. Yeast is a fast-
growing, easy-to-cultivate organism, and it does not require serum for growth. 
Whereas typical mammalian MCF7 and HeLa cell line assays require several days of 
growth in a steroid-free serum and a 16 hour long incubation with the test chemicals 
(Balaguer et al. 1999), yeast grows overnight and the assays can be performed during 
one working day (Leskinen et al. 2005). Yeast assays are more robust and cost-
efficient, and no specialized performers or instruments are needed. In addition, yeast is 
generally more tolerant towards toxicity of non-purified complex samples compared to 
mammalian cells. Yeast assays have already been used to screen for hormonal activity 
in complex samples (Bovee et al. 2008, Bovee et al. 2009b, Inoue et al. 2011) and 
pure chemicals (Kamata et al. 2008). Thus, yeast assays are a valuable addition to the 
battery of NR-dependent screening methods. 
 
1.2.2. Principle of yeast-based nuclear receptor bioreporter assays 
The ability of yeast to reproduce the NR signaling pathway is remarkable since 
yeast does not have mammalian cell-like NRs. However, some yeast receptors with 
similarly functioning domains and cofactors have been discovered, suggesting a 
common ancestor for these receptors (Phelps et al. 2006, Näär and Thakur 2009). 
Yeast NR assays detect either ligand-dependent NR-mediated transcriptional 
activation of a reporter gene (Figure 2A), or ligand-dependent interaction of the 
receptor with a cofactor protein (the yeast two-hybrid method, Figure 2B). In 
transcription activation assay (Figure 2A) the ligand-bound NR binds the hormone 
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receptor responsive elements (HRE) inserted on the promoter of the reporter gene. 
Then transcriptional activation of the reporter takes place via recruitment of various 
transcription cofactors of yeast origin, for example chromatin remodeling complexes or 
histone modification factors (mechanisms of NR functioning in yeast reviewed by 
Kennedy 2002). 
In yeast two-hybrid method (Figure 2B) the ligand binding domain of the receptor is 
coupled to activation (AD) or DNA-binding domain (BD) of the Gal4 transcription factor. 
In this method, the ligand-bound receptor interacts with a chosen cofactor protein, and 
the complex activates the expression of a reporter protein by binding to Gal4-specific 
upstream activating sequence (UAS) on its promoter. 
 
 
Figure 2. Principle of yeast-based NR bioreporter assays. A: Transcription activation 
assay; B: Yeast two-hybrid assay. HRE = hormone receptor responsive element, UAS 
= upstream activating sequence, AD = activation domain, BD = binding domain. 
The expression of a reporter protein is coupled to the ligand-dependent activation of 
a NR. Thus, the reporter protein produces a quantifiable signal that is dependent on 
the compound concentration. By comparing to the dose-response curve, the activity of 
an unknown sample can be translated into an equivalent concentration of a 
corresponding reference compound, such as 17β-estradiol for estrogen receptor. 
Majority of the current yeast-based NR assays use β-galactosidase enzyme as a 
reporter. β-galactosidase catalyses the breakdown of a chromogenic substrate, and 
the absorbance resulting from the color change is measured. Despite its popularity, β-
galactosidase has some drawbacks. To produce better signal, cell lysis is usually 
needed (Schultis & Metzger 2004). Bioluminescent or fluorescent substrates for β-
galactosidases can also be used, although they require either an extra incubation time 
or cell lysis (Balsiger et al. 2010, Berg et al. 2000). 
Luciferases are enzymes that produce bioluminescence by oxidation of a substrate. 
Luciferases are favored in cell-based high throughput format assays because of low 
natural background and high specific activity (Fan & Wood 2007). Yeast-based NR 
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assays with luciferase enzyme from firefly as a reporter do not require cell lysis but 
they do need addition of substrate (Leskinen et al. 2005 & 2008). Luciferase enzyme 
from bacteria together with genes required for the biosynthesis of bioluminescence 
reaction substrate (the lux-operon) has also been used as reporter in yeast 
(Sanseverino et al. 2005, Eldridge et al. 2007). Although no substrate addition is 
needed, the signal is low compared to firefly luciferase. 
Fluorescent proteins have been extensively used in imaging structures and 
functions of live cells (reviewed by Chudakov et al. 2010). An astonishing variety of 
fluorescent proteins with different palette of excitation and emission wavelengths exist 
today. The application repertoire is also wide, for example, imaging of tissue and cell 
architecture, protein and cell organelle localization, protein interaction, and promoter 
activity. Green fluorescent protein (GFP) is probably the best characterized and used 
of the fluorescent proteins. It has also been used as a reporter protein in yeast NR 
assays. A codon-optimised yeast-enhanced GFP (yEGFP) (Cormack et al. 1997) is 
used in several yeast NR assays (Bovee et al. 2004, 2007; & 2011, Chatterjee et al. 
2008). The greatest benefit of yEGFP and other fluorescent proteins is that no 
substrate addition is needed. However, because of high natural background of green 
fluorescence, long ligand exposure times are usually needed with yEGFP to obtain a 
sufficiently high signal-to-background ratio (Bovee et al. 2007). 
Growth reporter proteins are another class of reporters. They are metabolically 
essential enzymes that have been removed from the genome of the yeast that is used 
as a host strain in the reporter assay. For example, imidazole glycerol phosphate 
dehydratase (His3) synthesizes amino acid histidine. If no histidine is added externally, 
these strains are able to grow only in the presence of a receptor-activating ligand. 
Because these methods are based on cell growth, they are suitable for HTS, although 
cell growth is somewhat time-consuming compared to other reporters. Growth reporter 
proteins have been mainly used as a genetic selection tool for NR mutant libraries in 
yeast (Chen & Zhao 2005, Miller & Whelan 1998, Schwimmer et al. 2004). 
Test chemicals and solvents can exhibit non-NR-dependent effects such as toxicity 
or growth promotion, which can cause false negative or positive results of the NR 
assay. A popular approach to correct these effects is to measure cell density after 
incubation with the chemical (Sohoni & Sumpter 1998, Bovee et al. 2004). Although 
this is a practical approach, it only reflects general toxicity on yeast but not possible 
inhibitory effect on the reporter protein. The toxic effects on yeast metabolism and 
reporter protein can be corrected by using a control strain constitutively expressing the 
reporter protein in parallel with the NR yeast strain (Michelini et al. 2005, Leskinen et 
al. 2005, Eldridge et al. 2007). In this method, the only change in reporter signal is 
measured. 
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1.2.3. Current yeast-based nuclear receptor bioreporter assays 
Yeast cell NR-based bioreporter assays are useful in detection of endocrine 
disrupting potential of chemicals as well as environmental samples. Yeast NR assays 
are especially suitable for robust initial screening of chemicals and samples for further 
verification. However, because yeast NR assays do not have intrinsic NR signaling 
system, conclusions about toxicity on a whole organism-level cannot be drawn. 
To date, there is a large selection of different yeast NR bioreporter assays 
available. Many of the assays are also capable of detecting antagonistic activity of 
chemicals. Some yeast NR bioreporter assays have also been internationally validated 
(Bovee et al. 2009a & 2009b). 
The first and most studied yeast NR bioreporter assays were developed using the 
human estrogen receptor. Estrogen receptor (ER) is a steroid hormone sensing 
nuclear receptor that regulates genes involved in growth, development, differentiation, 
and activity of tissues. The natural ligands for ER are 17β-estradiol, estrone, and 
estriol. In human, two subtypes of ER are known: ERα and ERβ.  
The first yeast ER bioreporter assay was the YES (Yeast Estrogen Screen) assay 
utilizing β-galactosidase reporter (Routledge & Sumpter 1996). Nowadays there are 
ER assays with firefly luciferase (Leskinen et al. 2005 & 2008), yEGFP (Bovee et al. 
2004), and even bacterial luciferase-luciferin system (Sanseverino et al. 2005) as 
reporter proteins (Table 1). 
Yeast ER assays are relatively sensitive with detection range starting from sub-
nanomolar concentrations of 17β-estradiol (Table 1). Several other chemicals have 
also been shown to activate the ER in yeast. These chemicals include, for example, 
natural steroid hormones, phytoestrogens, diethyl stilbestrol, bisphenol A, alkyl 
phenolic compounds, plasticizers, parabens, PCB compounds, pesticides, and 
pharmaceuticals (Sohoni & Sumpter 1998, Leskinen et al. 2005, Schultis & Metzger 
2004, Bovee et al. 2004, Murk et al. 2002, Routledge & Sumpter 1997, Sanseverino et 
al. 2009, Nishikawa et al. 1999, Shiraishi et al. 2003). Several of these chemicals have 
also been shown to be active ligands of ER in mammalian cell assays (reviewed by 
Giesy et al. 2002). 
As mentioned above, yeast-based ER bioreporter assays usually detect ER 
agonists, but assays that are able to detect ER antagonists have also been developed 
(Table 1). Chemicals such as tamoxifen, hydroxytamoxifen, and ICI 182780 have 
shown partial or full antagonism in some yeast assays, whereas in others they are 
detected as agonists only (Sohoni & Sumpter 1998, Leskinen et al. 2005, Kolle et al. 
2010, Bovee et al. 2008, Legler et al. 2002). Yeast ER assays have been used to 
screen for ER antagonists, even at a comparable accuracy with a mammalian cell 
assay (Bovee et al. 2010, Kolle et al. 2010). 
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Table 1. Yeast-based nuclear receptor bioreporter assays. 
nd: not determined 
Yeast NR assay Reporter Incubation time 
Reference 
compound 
Detection 
limit EC50 
Antagonism 
detection Reference 
hERa transactivation β-galactosidase 3-4 days 
17β-estradiol 
- 0.22 nM yes Beresford et al. 2000 
Yeast two-hybrid hERα β-galactosidase 4 h 0.1 nM - nd Nishikawa et al. 1999 
hERα transactivation bacterial luciferase 6 h 0.045 nM 0.24 nM nd Sanseverino et al. 2005 
hERα transactivation firefly luciferase 2.5 h 0.03 nM 0.5 nM partial Leskinen et al. 2005 
hERβ transactivation firefly luciferase 2.5 h 0.1 nM 0.5 nM partial Leskinen et al. 2005 
hERα transactivation yEGFP 4 h - 0.4 nM yes Bovee et al. 2004 
hAR transactivation β-galactosidase 40 h 
dihydro 
testosterone 
- ~1 nM yes Sohoni & Sumpter 1998 
hAR transactivation β-galactosidase 16 h 0.1 nM 4 nM yes Chatterjee et al. 2007 
Yeast two-hybrid hAR β-galactosidase 2 h - 13 nM yes Li et al. 2008a&b 
hAR transactivation bacterial luciferase 3-4 h 2.5 nM 9.7 nM nd Eldridge et al. 2007 
hAR transactivation firefly luciferase 2.5 h 0.5 nM 5.5 nM yes Leskinen et al. 2005 
hAR transactivation yEGFP 24 h 3 nM 33 nM yes Bovee et al. 2007& 2009b 
hPR transactivation β-galactosidase 4 h 
progesterone 
0.1 nM 0.5 nM yes Gaido et al. 1997 
hPR transactivation yEGFP 24 h - 1 nM yes Chatterjee et al. 2008 
hAhR transactivation firefly luciferase 3.5 h 
benzo[a]-pyrene 
3.3 nM 190 nM nd Leskinen et al. 2008 
hAhR transactivation β-galactosidase 18 h - 40 nM nd Miller 1997 
hAhR+hER transactivation β-galactosidase 4-6 days - 180 nM nd Kawanishi et al. 2008 
hRXR&RAR transcactivation β-galactosidase 16 h 9-cis-retinoid 
acid 
- 50-150 nM nd Allegretto et al. 1993 
Yeast two-hybrid hRXR β-galactosidase 4 h - > 100 nM nd Nishikawa et al. 2004 
Yeast two-hybrid hRXR β-galactosidase 2 h - 150 nM yes Li et al. 2008b 
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ER yeast bioreporter assays have also been used to measure estrogenic activity of 
environmental samples, such as waste water and environmental water (Balsiger et al. 
2010, Rutishauser et al. 2004, Salste et al. 2007, Inoue et al. 2011, Murk et al. 2002, 
Fine et al. 2006, Pinto et al. 2005). Also sediment extracts, moisturizer lotions, and 
diverse biological samples  have been successfully analyzed (Grund et al. 2011, 
Leskinen et al. 2005, Bovee, et al. 2009a, Garritano et al. 2006, Becue et al. 2011). 
Androgen receptor (AR) regulates genes responsible for male reproduction and 
development. The natural ligands of AR are testosterone and dihydrotestosterone. 
Xenobiotic compounds binding to AR act mainly in antagonistic fashion. Such 
chemicals include, for example, fungicide vinclozolin and DDT. Some estrogenic 
compounds also work as anti-androgens in yeast assay (Sohoni & Sumpter 1998). 
Many AR ligands act as antagonists in yeast assays while only few exhibit agonistic 
effects (Sohoni & Sumpter 1998, Bovee et al. 2007 & 2008, Kolle et al. 2010). Thus, 
detection of antagonism is especially important when AR-binding compounds are 
screened. 
Examples of yeast AR bioreporter assays are presented in Table 1. The yeast-
based AR assays have been used to screen for (anti)androgenic chemicals such as 
steroid hormones, plant-derived compounds, flame retardants, pesticides, and phenolic 
compounds (Bovee et al. 2010, Kolle et al. 2010, Sanseverino et al. 2009, Li et al. 
2008a). Complex samples such as hair samples, dietary supplements, calf urine and 
feed, waste water, and pulp and paper mill effluents have also been measured (Becue 
et al. 2011, Rijk et al. 2009, Bovee et al. 2009b, Michelini et al. 2005, Chatterjee et al. 
2007). 
Progesterone is another steroid hormone that binds to nuclear receptor and 
regulates reproduction, and preparation and maintenance of uterus in pregnancy 
(reviewed by Li X. et al. 2004). Together with estrogen hormone, progesterone 
regulates cell proliferation and differentiation in reproductive tissues. The few 
chemicals tested for PR so far have mainly showed anti-progesterone-like, i.e. 
antagonistic, activity. It is, thus, important to screen antagonistic effect in addition to 
agonistic effect in PR assays as well. Examples of PR yeast bioreporter assays are 
presented in Table 1. Because high progesterone concentrations seem to inhibit yeast 
growth (Gaido et al. 1997), the ligand exposure times have to be kept as short as 
possible. The PR yeast bioreporter assays have been used to analyze, for example, 
doping compounds, pesticides, nonylphenol, and endosulfan, and waste waters (Death 
2004, Chatterjee et al. 2008, Li et al. 2008b & 2011). 
Aryl hydrocarbon receptor (AhR) (reviewed by Safe 2001) is a mammalian nuclear 
receptor. It is associated with activation of the drug and xenobiotic metabolizing 
enzymes, for example, cytochrome P450 1A1 mono-oxygenase. AhR signaling 
pathway can also cross-talk with other NR pathways, for example ER, causing 
estrogenic and anti-estrogenic effects (Ohtake et al. 2003, Kawanishi et al. 2008). AhR 
is also known as the dioxin receptor. While the natural ligand of AhR yet remains 
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unconfirmed, this receptor has been shown to bind and be activated by dioxin-like co-
planar aromatic substances such as 2,3,7,8-tetrachloro-dibentzo-p-dioxin (TCDD) 
(reviewed by Safe 2001, and Janosek et al. 2006). Other well-known AhR ligands are 
benzo[a]pyrene, PCBs, and PAHs. In addition, compounds like tryptophan, indole, 
indole acetic acid, tryptamine, and indole-3-carbinol have been detected to activate the 
receptor (Miller 1997). 
Only few AhR yeast bioreporter assays have been developed so far (Table 1). A 
yeast bioreporter assay with both ER and AhR has been developed to measure AhR 
transactivation potency on ER signaling pathway (Kawanishi et al. 2008). The AhR 
yeast bioreporters have been used to measure water samples, sediment samples, and 
different chemicals (Kawanishi et al. 2008, Leskinen et al. 2008, Kamata et al. 2009, 
Allinson et al. 2011).  
Natural retinoids, such as vitamin A, act via the nuclear receptors retinoid acid 
receptor (RAR) and retinoic X receptor RXR (review by Inoue et al. 2010, and Janosek 
et al. 2006). They control many functions including embryonic development, apoptosis, 
vision, bone development, and nervous and immune systems. RAR and RXR can form 
heterodimers with each other, and RXR also with other NRs, for example, thyroid 
hormone receptor, peroxisome proliferator-activated receptors, vitamin D receptor, 
estrogen receptor, and liver X receptor (Aranda & Pascual 2001, Nakanishi et al. 
2005). This enables numerous different regulatory modes for the receptors, depending 
on the cellular environment. 
Of the natural retinods, all-trans-retinoic acid (atRA) and 9-cis-retinoic acid (9cRA) 
(Figure 1) bind to RAR, whereas only 9cRA seems to bind to RXR. Perhaps the best-
known exogenous compound binding to RXR are organotin compounds such as 
tributyl tin (TBT) and triphenyl tin (TPT) (Figure 1) (Nishikawa et al. 2004, Nakanishi et 
al. 2005). The most bioactive forms are tri-substituted forms, while di-and mono-
substituted are less active.  
The functioning of RARs and RXRs in yeast was demonstrated by Hall et al. (1993) 
and Heery et al. (1993 & 1994). However, only few bioreporters utilizing RAR or RXR 
have been developed so far (Table 1). These bioreporters have been used to 
determine RAR and RXR agonism and antagonism of several chemicals, such as 
pesticides, parabens, phenols, phthalates, but also waste water (Kamata et al. 2008, Li 
et al. 2008b, Inoue et al. 2011). 
Yeast-based assays have been developed for other nuclear receptors in addition to 
the ones discussed above. These include, for example thyroid hormone, and 
glucocorticoid and mineral corticoid receptors (Nishikawa et al. 1999, Miller et al. 
2010). Together, the different yeast NR bioreporter assays make an extensive battery 
for testing endocrine disrupting activity of chemicals and samples. 
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1.3. High-throughput screening of EDCs 
High throughput screening (HTS) refers to a methodology in which large libraries of 
compounds and environmental samples can be effectively analyzed for their biological 
activity (Clemons et al. 2009). This requires automation, miniaturization of assay 
formats, and efficient data analysis (Wölcke & Ullmann 2001, Mayr & Bojanic 2009).  
Miniaturization of an assay aims to reduce assay volume and increase screening 
capacity. However, miniaturization might encounter challenges, such as effects caused 
by altered reagent stability due to changed surface:volume ratio, evaporation, and 
adsorption. Good data quality should also be retained. In order to accomplish this, an 
ideal HTS assay should have both high signal-to-background ratio and low standard 
deviation (Zhang 1999). It is also important to ensure as low variability in cell number 
as possible in the low volumes used (Wölcke & Ullmann 2001). This is accomplished 
by proper suspension of cells and accurate liquid handling. 
In future, miniaturized cell-based assays are predicted to become more and more 
important as primary screening tools (Wölcke & Ullmann 2001). Already now 384-well 
plate format is routinely used in cell-based assays (Mayr & Bojanic 2009), and an 
increasing number of 1536-well format assays and even higher are being developed 
(Clemons et al. 2009). 
Several mammalian-cell-based NR assays have already been miniaturized even up 
to 3456-well plate format (Shi et al. 2005, Peekhaus et al. 2003, Chin et al. 2003, 
Wilkinson et al. 2008). Almost all yeast-based NR bioreporter assays, however, are still 
performed in 96-well plate formats, and only very few have been miniaturized into 384- 
and 1536-well plate formats (Berg et al. 2000). It is certain that in future there is a 
growing need for miniaturized yeast-based NR assays. 
Yeast-based NR bioreporter assays have several properties that make them well 
suitable for HTS. They are robust, inexpensive, and generally easy and fast to perform. 
They have potential to be applied to high density well plate formats and automated 
assays. The current yeast NR assays use many different reporter proteins. An ideal 
reporter for high-throughput screening purposes should require minimal handling. 
Additional steps like centrifugation, extra incubations, and addition of substrate or cell-
disrupting agents are poorly suited to HTS because they increase the risk of cross-
contamination and assay duration. The modern yeast-based NR assays require 
relatively short incubation times, even as short as 2.5 hours (Leskinen et al. 2005). 
Yeast cell cultivation is also fast compared to mammalian cell cultivations. By 
combining the different yeast assays for different nuclear receptors (Table 1) into HTS 
assay batteries it is possible to screen for several nuclear receptor-mediated effects of 
chemicals. 
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1.4. Bioreporters for specific detection of chemicals 
NR bioreporters are extremely useful in determining the total hormonal activity of a 
complex sample. However, no conclusions about the identity of chemicals in the 
sample can be done. In environmental analytics, the lack of chemical specificity of the 
bioreporters has been regarded as their main drawback of (Bovee & Pikkemaat 2009).  
The identity of specific chemicals in the sample can be determined using chemical 
analysis methods. Although these methods may be more sensitive than cell-based 
bioreporters, they are usually more expensive than cellular assays, and they require 
specialized instruments and users, and heavy sample preparations. Bioreporters are 
easy to use, they are suitable to HTS of large numbers of samples, and they usually 
require minimal sample handling. Bioreporters are also considered a good method to 
assess the bioavailable fraction of contaminants in the environment (Liao et al. 2006). 
Bioreporters for specific detection of chemicals could have use in cost-efficient 
monitoring of contaminants. 
 
1.4.1. Modification of nuclear receptor ligand-binding properties 
Properties and functions of proteins can be changed towards desired way by using 
directed evolution (Jäckel et al. 2008). In directed evolution, DNA sequence of a 
protein is mutated randomly, and mutants with desired functions are selected/screened 
from the population of different mutants. The process of mutagenesis and 
selection/screening can also be repeated several times using mutants with most 
desirable properties. In this text, selection refers to process where the whole 
population of mutants is tested against a chosen property, whereas screening means 
testing individual mutants.  
NRs have been an easy target for directed evolution because of the easiness to link 
the changes in ligand-induced activation to screening and selection. For example, 
estrogen receptor and retinoid X receptor have been mutated to enhance the potency 
of weak or even completely novel ligands (Islam et al. 2009, Chen & Zhao 2005, Chen 
et al. 2004, Chockalingam et al. 2005, Schwimmer et al. 2004). In addition, hER has 
been modified to bind testosterone and even progesterone and corticosterone, which 
have no detectable affinity to the wild type receptor (Chen & Zhao 2005). 
Mutations can be generated randomly on a whole or on a limited sequence or 
sequences of a gene, or by designing specific mutations on selected residues, or even 
combining several different approaches. Mutations in NRs have been generated using 
error-prone PCR (Miller & Whelan 1998, Chen & Zhao 2005), and oligonucleotide-
based mutagenesis in which specific (Chen et al. 2004) or random (Schwimmer et al. 
2004, Chockalingam et al. 2005) mutations are targeted on chosen amino acids. 
Combinations of methods have also been popular (Islam et al. 2009, Chockalingam et 
al. 2005, Chen et al. 2004). Several rounds of mutagenesis is usually needed to 
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produce NRs with desired ligand-binding properties (Islam et al. 2009, Chockalingam 
et al. 2005, Chen & Zhao 2005). 
Random mutations can be generated by using oligonucleotides, in which the 
mutagenized areas are synthetized using only certain bases. For example, using a 
codon sequence NNS, in which N=any base and S=G or C, enables insertion of 
codons for all 20 possible amino acids. Another approach is to use “doped” 
oligonucleotides, i.e. in incorporation of certain bases, there are other bases in lower 
proportion compared to the original base. In this manner, relatively long stretches of 
sequence can be randomly mutated even at a relatively high mutation frequency 
compared to error-prone PCR. Another advantages of this method is to create 
mutations in only those stretches of sequence that are of particular interest. This 
method has been used in a study where the metal binding properties of a bacterial 
metal-binding protein MerR were directed towards chosen metals (Hakkila et al. 2011). 
The number of possible mutant variants generated by a mutation method defines 
the theoretical diversity of a mutant library. However, transformation efficiency limits 
the diversity by limiting the true size of the library. In addition, possibility to go through 
the whole existing library to find desired mutants depends on the efficiency of the 
selection/screening methods. Indeed, there is a need for NR mutant library 
selection/screening methods able to cover libraries with more than 4×105 mutants 
(Chen & Zhao 2005). 
The screening methods used for nearly all yeast NR mutant libraries are based on 
chemical complementation, i.e. growth-based reporter proteins (Islam et al. 2009, 
Chen & Zhao 2005, Chen et al. 2004, Chockalingam et al. 2005, Schwimmer et al. 
2004). Although relatively efficient, these methods have not been designed to actively 
implement screening of reduced affinity towards an undesired ligand. Only one method 
has so far introduced this kind of negative screening (Shaffer et al. 2012). 
Flow cytometry is an efficient method to screen for certain type of cells even in a 
very large population (Daugherty et al. 2000). For example, the fluorescence-activated 
cell sorter can handle as many as 105 clones per second (Aharoni et al. 2005). Flow 
cytometry is based on counting and separating cells according to differential size and 
biomarker expression. Even thousands of cells per second can be analyzed by forcing 
cells into a narrow fluid stream. This high throughput screening tool has already been 
used for bacterial metal-binding receptor mutant library (Hakkila et al. 2011). 
In order to develop chemical-specific NRs for the use of environmental analytics, 
there is a need for a methodology combining a simple but powerful mutation method 
with an efficient mutant library screening method which is able to combine positive and 
negative selection of target ligands.  
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2. AIMS OF THE STUDY 
The aims of this thesis study were as follows: 
 
1. To develop a chemical-specific yeast-cell-based bioreporter for monitoring of 
bisphenol A in complex environmental samples. 
 
2. To generate a method to select a mutant receptor library for both positive and 
negative ligand-binding affinities, and to test the efficiency of the used mutation 
and selection methods using human estrogen receptor α. 
 
3. To adapt the existing yeast-based bioreporter assays for high throughput 
screening (HTS) by optimizing their use in 384 and 1536 well plates. 
 
4. To develop a new yeast-based bioreporter for organotin compounds by utilizing 
human retinoid X receptor. 
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3. SUMMARY OF MATERIALS AND METHODS 
3.1. Yeast strains 
The yeast strains and constructs used in this study are mainly based on the 
previous work by Piia Leskinen (Leskinen et al. 2003, 2005 & 2008). All 
Saccharomyces cerevisiae yeast bioreporters described in this thesis have been 
constructed in the parent strain BMA64-1A (Baudin-Baillieu et al. 1997). 
The yeast strains used in this study are presented in Table 2. For all bioreporter 
assays, the yeasts were cultivated in selective synthetic minimal medium (see detailed 
description in publications indicated in Table 2). 
Table 2. Yeast strains used in this study. 
Yeast strain Expressed receptor Reporter protein(s) References 
BMAERE/BPA-R BPA-R firefly luciferase II 
BMAEREyEGFPHIS+ (mutant ER library) yEGFP-His3 fusion I 
BMAEREluc/RXR-ER hRXR+hERα DBD firefly luciferase IV 
BMAEREluc/ERα hERα firefly luciferase Leskinen et al., 2005 
BMAEREluc/ERβ hERβ firefly luciferase Leskinen et al., 2005 
BMAAREluc/AR hAR firefly luciferase Leskinen et al., 2005 
BMAXREluc/AhR hAhR firefly luciferase Leskinen et al., 2008 
BMA64/luc none firefly luciferase Leskinen et al., 2005 
 
The bisphenol A-specific receptor (BPA-R) yeast bioreporter (II) was constructed 
using the BMAEREluc reporter yeast strain (Leskinen et al. 2005) in which firefly 
luciferase reporter protein is under the control of estrogen receptor-inducible promoter. 
In the BPA-R strain, the wild type estrogen receptor of the parental BMAEREluc/ERα 
was replaced by P4E C8 mutant (I) of human estrogen receptor α. 
The yeast strain BMAEREyEGFPHIS+ used for mutant library selection (I) was 
constructed using the plasmid YIpEREluc (Leskinen et al. 2003) as a backbone. The 
firefly luciferase reporter gene was replaced with a fusion of two reporter genes: the 
yeast-enhanced green fluorescent protein (yEGFP), and imidazole glycerol phosphate 
dehydratase (His3) genes, yielding the plasmid YIpEREyEGFPHIS+ (Figure 3). The 
resulting reporter construct produced a fusion protein of yEGFP-His3 in estrogen 
receptor-inducible manner. The linker connecting the yEGFP and His3 reporter 
proteins consisted of a flexible triplicate glycine-serine amino acid sequence (Figure 3).  
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Figure 3. Plasmid map of YIpEREyEGFPHIS+. 
The BMAEREluc yeast strain (Leskinen et al. 2005) was used to construct the 
hRXR-ER organotin yeast bioreporter strain (IV). The DNA binding domain (DBD) of 
human retinoid X receptor (hRXR) (amino acids 133-208) was replaced with the DBD 
of human estrogen receptor α (hERα) (amino acids 176-282). The hybrid receptor was 
designed according to the sequences of hRXRα (mRNA accession number 
NM_002957) and hERα (mRNA accession number NM_000125). The resulting 
chimeric receptor gene was optimized for yeast expression and synthesized by 
GenScript Corporation (USA). The hybrid gene was cut from carrier plasmid pUC57 
with BamHI/SalI digestion and ligated to the corresponding sites on plasmid pESC-
TRP (Stratagene, USA) yielding plasmid pESC-RXR-ER (Figure 4.). The hybrid 
receptor was expressed constitutively under strong galactose-inducible promoter of the 
pESC-plasmid. 
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Figure 4. Plasmid map of pESC-RXR-ER. TRP = N-(5'-phosphoribosyl)anthranilate 
isomerase, ori = origin of replication. 
3.2. Yeast bioreporter assay protocols 
The miniaturized yeast bioreporter assay protocols used in this study are shown in 
Table 3. The 384-well format assay protocol was used in publications I, II, III, and IV. 
The 1536-well format assay protocol was used in publication III. The original 96-well 
format assay protocols have been published previously (Leskinen et al. 2005 & 2008). 
Conditions were optimized for the miniaturized assays using the hERα bioreporter 
by measuring the 17β-estradiol standard curve with varying D-luciferin substrate 
concentrations (0.1 mM-2 mM) and incubation times (1-4.5 h). 
Liquid handling of all well plates was done using Biomek NXP Laboratory Automation 
Workstation (Beckman Coulter, USA) fitted with disposable pipette tips. All well plates 
were imaged using Victor3 1420 Multilabel Counter (PerkinElmer/Wallac, Finland). 
The BPA-R and RXR-ER yeast bioreporter assay characterizations were performed 
using the 384-well plate assay protocol (Table 3), except for the RXR-ER bioreporter 
sediment analyses which were performed using the 96-well plate assay protocol. 
 
 
 
 
 
pESC-RXR-ER 
8.0 kb 
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Table 3. Yeast bioreporter assay protocols. 
1. Inoculate an overnight culture at SD medium. Culture at 30°C in an incubating shaker. 
2. Dilute the culture to get to optical density 0.4. at 600 nM (OD600). Culture at 30°C in a 
incubating shaker until the OD600 reaches 0.6-0.7. 
1536-well plate assay 
protocol (III) 
384-well plate assay 
protocol (III) 
96-well plate assay 
protocol (Leskinen et al. 
2005 & 2008) 
3. Pipette 4 µL sample onto 
well plate. 
3. Pipette 5 µL sample in well 
plate. 
3. Pipette 10 µL sample in well 
plate. 
4. Mix D-luciferin substrate 
stock solution (10 mM) with 
the yeast culture into final 
concentration of 0.5 mM. 
4. Mix D-luciferin substrate 
stock solution (10 mM) with 
the yeast culture into final 
concentration of 0.5 mM. 
4. Add 90 µL yeast culture. 
5. Add 4 µL yeast+substrate 
mixture onto well plate. 
5. Add 45 µL yeast+substrate 
mixture onto well plate. 
5. Shake briefly, cover with a 
lid and incubate at 30°C for 
2.5-3.5 h. 
6. Shake briefly, cover with a 
lid and incubate at 30°C for 
4.5 h. 
6. Shake briefly, cover with a 
lid and incubate at 30°C for     
3 h. 
6. Add 100 µL of 1 mM D-
luciferin substrate and shake 
briefly. 
7. Measure luminescence signal with a plate reader set in luminescence mode for 1 s well-1. 
 
3.3. Mutagenesis of hERα and selection of the mutant receptor library (I) 
The human estrogen receptor α was mutated in three regions of the ligand binding 
domain (LBD). The regions were 13, 11, and 12 amino acids in length located on 
helices 3, 8, and 11 of the LBD, respectively.  
Mutations were generated using randomized oligonucleotides. Three ‘‘doped’’ PCR 
oligos, one for each region to be mutated, were designed so that in synthesis reaction 
of the randomized regions 79% of the original bases and 7% each of the other three 
bases were used. All primers were synthesized by Sigma–Aldrich. The mutated LBDs 
were constructed from four separately generated PRC-products using OE-PCR (An et 
al. 2005). 
Mutant receptor library was generated in the BMAEREyEGFPHIS+ selection yeast 
strain by co-transforming the mutated LBDs together with the linearized expression 
plasmid pG1/ER(G) (Liu & Picard 1998) using the high-efficiency lithium acetate 
method (Gietz & Woods 2002). The expression plasmid regenerated in the yeast cells 
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by homologous recombination between the matching regions at the ends of the 
plasmid backbone and the mutated LBD. Ten parallel transformations were performed. 
A genetic selection system comprising of positive selection against BPA affinity and 
negative selection against 17β-estradiol (E2) was used. The positive selection was 
performed on histidine-free agar plates containing 5 mg l-1 BPA. Cells were grown at 
30°C for 2 days, after which they were harvested and pooled. Next, cells were selected 
for negative potency towards E2. Library cells were grown in liquid culture in the 
presence of 10 nM E2, after which they were subjected to flow cytometric sorting. The 
sorting was performed at the Turku Centre for Biotechnology Cell Imaging Core (Turku, 
Finland) using BD FACSVantage flow cytometer. Cells with low fluorescent signal were 
collected, after which they were plated again on histidine-free agar plates containing 5 
mg l-1 BPA. 
Cells growing on the agar plates were harvested, and mutant receptor plasmids 
were recovered and transformed into the luminescent reporter yeast strain 
BMAEREluc. Individual transformants were picked and screened for luminescence 
induction upon exposure on BPA and E2 on 384-well plates using the protocol 
described in Table 3. Plasmids from the transformants with desired properties were 
recovered and the mutant receptor genes sequenced. 
The ligand-binding properties of the desired mutant receptors were further tested 
with other estrogenic chemicals using the 384-well plate protocol described in Table 3. 
 
3.4. Waste water sample treatment (II) 
Waste water effluent and influent samples of 1 l volume were collected from the 
Viikinmäki waste water treatment plant in Helsinki, Finland on December 7th and 13th 
2011. The samples were divided into 30 ml aliquots, and three samples were spiked 
with either 0.2 mg l-1 (0.88 µM) BPA, 0.8 nM E2, or both. 
The samples were frozen in -80 °C after which they were freeze dried for about 40 
h into near dryness using Edwards Super Modulyo freeze drier (Severn Science, 
Bristol, UK). The freeze dried samples were re-suspended into 3 ml of Milli-Q water in 
order to obtain a total of 10-fold concentration. 
In addition, three influent samples (volume 3 ml) were spiked after freeze drying 
using the same theoretical concentrations (2 mg l-1 BPA and 8 nM E2) as the 
concentrated samples spiked before freeze drying were expected to have. 
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4. SUMMARY OF RESULTS AND DISCUSSION 
4.1. Modification of hERα ligand specificity (I) 
Human estrogen receptor α (hERα) ligand binding properties were modified in this 
study. The aim was to create a novel receptor with increased potency towards 
bisphenol A, which is a weak ligand of hERα, and at the same time to decrease the 
potency of this receptor towards natural ligand, 17β-estradiol (E2). 
Our approach in creating mutations in the hERα ligand binding domain (LBD) was 
to target a reasonably high frequency of random mutations on selected regions. The 
purpose of high frequency of mutations was to test whether in this manner only one 
round of mutagenesis would be sufficient to generate desirable mutants. In other NR 
mutation studies, several rounds of mutations and screening have been performed 
(Chockalingam et al. 2005, Islam et al. 2009, Schwimmer et al. 2004). 
The chosen mutation areas were located on three different α-helices that have been 
shown to line the ligand binding cavity in the LBD, and in which some amino acid 
residues are in contact with the native ligand (Brzozowski et al. 1997). A total of 108 
bases on the hERα LBD were subjected to a 21% chance of mutation each, yielding an 
expected average of 22-23 base mutations per receptor. In theory such a high number 
of mutations require a fairly large mutant receptor library in order to include as many 
mutant variants as possible. However, creating such a comprehensive library is 
difficult. This was also the case in our study, mainly due to rather low transformation 
efficiency (9×105 colony forming units /µg vector DNA), resulting in a library with 
approximately 6.8×106 mutant hERα variants. 
Exploring a large library requires an efficient method to select for mutants with 
desired properties. In this study, the library was selected for two kinds of affinities: 
positive potency for BPA, and decreased potency for E2. The selection and screening 
protocol is illustrated in Figure 5. Library size after each step is shown. 
The positive and negative selections were performed using the genetic selection 
yeast strain BMAEREyEGFPHIS+ which had a fusion reporter protein comprising of 
yeast enhanced green fluorescent protein (yEGFP) and histidine auxotrophy-
complementing His3-enzyme. The synthesis of the reporter protein was induced by a 
ligand-bound receptor, allowing cell growth in histidine-free medium and producing 
fluorescence. 
In the first selection step, positive growth-based selection was used to enrich the 
library with BPA-inducible mutants. However, it was anticipated that this step would 
also enrich the proportion of constitutive mutants. It has been shown that a truncated 
hER lacking the LBD functions in a constitutive manner in yeast cells (Metzger et al. 
1995, White et al. 1988). Thus, a stop-codon formation in a mutant receptor was 
expected to yield a constitutive phenotype. Flow cytometric sorting of cells with low 
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fluorescence was used to decrease the proportion of both E2-inducible and constitutive 
mutants in the library.  
After the flow cytometric selection step, the GFP-expressing genetic selection yeast 
strain was replaced with the luminescence reporter yeast strain BMAEREluc (Leskinen 
et al. 2005). Individual mutants were picked from plasmid transformation agar plates 
and screened in high throughput 384-well plates. From a total of 470 individual tested 
mutants, 9 mutants with desired properties were identified.  
 
Figure 5. Screening protocol for the hERα mutant library. 
Although the flow cytometric selection was used to discard the mutants with high 
fluorescent signal, nearly 84% of mutants screened in the final selection step were 
identified as constitutive phenotype. However, without the negative selection step, 
finding the desired mutants would probably have required screening a far greater 
number of mutants. Of the total of 1.36×106 cells analyzed in the flow cytometer, about 
13% were sorted from gates P3 and P4 into test tube and plated. If assumed that the 
discarded 87% contained only undesirable mutants, and that they would have grown 
on BPA agar plates at similar efficacy as the sorted cells, then 100/13 = 7.7 times more 
individual cells (i.e. about 3,600) should have been screened in order to recover the 9 
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mutants with desired properties. Now only 470 individual mutants needed to be 
screened. 
The 9 mutants that exhibited the desired properties (induced with BPA but not with 
E2) had 7-15 base mutations contributing to 4-9 mutations on amino acid level. No 
mutations were detected on region 1, and two of the mutants had only 1-2 mutations 
on region 2, whereas the rest of the mutations were concentrated on mutation region 3. 
Three randomly chosen, non-selected mutants were sequenced to confirm that the 
mutation frequency was similar on all regions. These mutants contained mutations on 
regions 1 and 2 as well region 3 with base mutation frequencies ranging from 11-31% 
on all three regions. 
Amino acids in mutation region 3 (helix 11) form contacts with the D-ring of E2 
(Brzozowski et al. 1997). Although D-ring of E2 molecule has a hydroxyl group just like 
BPA, the D-ring is a non-aromatic 5-carbon ring whereas the rings in BPA molecule 
are aromatic phenol rings (Figure 1). The other two regions, in turn, form contacts with 
the A-ring, which is a phenol ring. Since the structural differences between the 
molecules are mainly located on the D-ring-end of E2, it is logical that mutations 
enhancing BPA binding and reducing E2 binding are located on LBD region contacting 
this end of E2. 
Of the identified mutants, 8 out of 9 showed higher potency towards BPA compared 
to the wild type hERα, the most sensitive mutant P3D E6 being about 7-fold more 
sensitive in respect of LOD (60 nM for mutant P3D E6 and 420 nM for hERα). Only 
mutant P4B E2 responded to E2 in the highest tested concentrations of 90 nM. When 
tested with other estrogenic compounds (estrone, estriol, diethyl stilbestrol, 
nonylphenol, hydroquinone, and β-sitosterol), the mutants showed no or very poor 
sensitivity compared to the wild type hERα. Mutant P4E C8 seemed to be the most 
specific of the mutants since it had lowest responses to these other estrogenic 
compounds. Thus, the developed mutation and screening method successfully 
produced mutants with increased potency towards BPA and decreased potency 
towards E2. 
The most sensitive and specific mutants P3D E6 and P4E C8 could be improved for 
bioreporter purposes by increasing specificity and sensitivity in order to lower 
responses to other chemicals and to allow detection of even lower concentrations of 
BPA. This could be done by further mutagenesis of the receptor, and possibly also by 
using lower concentration of BPA on the selection agar plates. Screening of individual 
mutants could in turn be facilitated by running the sorted cells again in the flow 
cytometer after some growing, thus further removing constitutive mutants. 
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4.2. Bisphenol A-specific yeast bioreporter (II) 
Using the mutated human estrogen receptor P4E C8 (created in publication I) the 
first yeast-cell-based bioreporter assay targeted for the detection of a single chemical, 
bisphenol A (BPA), was developed. The bisphenol A-specific receptor (BPA-R) yeast 
bioreporter assay was characterized and tested using mixtures of BPA and the native 
hormone 17β-estradiol (E2). In addition, a chemical cocktail containing some of the 
highest reported concentrations of BPA, E2, estrone, estriol, ethinyl estradiol, 
nonylphenol, and propyl paraben in waste water was also analyzed. BPA-R bioreporter 
was also tested for real-life analytics with waste water samples spiked with BPA, E2 
and both chemicals. 
The BPA-R bioreporter showed high specificity towards BPA in the tested 
concentrations (ranging from 525 µM to 9 nM of BPA, and from 1 µM to 1 pm E2, 
Figure 6.). Compared to the wild type hERα bioreporter, the BPA-R bioreporter was 
over 4-fold more sensitive towards BPA. E2 induced BPA-R bioreporter only in the 
highest tested concentration of E2 over its detection limit. This E2 concentration of 1 
µM  (i.e.  190  µg  l-1) is 1.7×105-times higher compared to the detection limit of hERα 
bioreporter (6 pM, i.e. 1.6 µg l-1). Although E2 was no longer a strong inducer of BPA-
R, it did have a clear inhibitory effect in concentrations starting at 62.5 nM (17 µg l-1) 
when E2 was tested with a constant BPA concentration of 3 µM. However, both 
inducing and inhibiting E2 concentrations are clearly higher than the highest measured 
E2 concentrations in influent waste water (150 ng l-1, Vethaak et al. 2005, L. Wang et 
al. 2012). Thus, even concentrated samples can be measured without risk of E2 
interfering the BPA-R bioreporter response. 
 
Figure 6. Dose-response curves of BPA-R and hERα bioreporters with bisphenol A 
(BPA) and 17β-estradiol (E2). Concentrations are given as the total analyte 
concentrations in the mixture with yeast cells (1 part sample +9 parts yeast culture). 
Values represent the mean ± standard error of the mean of five independent 
experiments, each comprising four parallel data points. LOD: limit of detection. 
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To mimic a situation where a highly contaminated water sample is concentrated 5-
fold, a chemical cocktail with estrogenic chemicals was prepared using a 5-fold 
concentrations of some of the highest reported concentrations of E2 (5×200 ng l-1), 
BPA (85 μg l-1), and other estrogenic chemicals: ethinyl estradiol (5×830 ng l-1), estrone 
(5×360 ng l-1), estriol (5×180 ng l-1), nonylphenol (5×40 μg l-1), and propyl paraben 
(5×2.8 μg l-1). BPA-R bioreporter exhibited similar induction with BPA-containing 
cocktail and sample with only BPA, whereas it did not respond to cocktail without BPA. 
The hERα bioreporter showed similar high induction with both cocktail samples, but 
BPA alone was below detection limit. Thus, BPA-R bioreporter succeeded in detecting 
BPA in a chemical cocktail with high concentrations of other potential environmental 
estrogenic chemicals. 
The LOD of BPA-R bioreporter for BPA was still rather high, 107 nM (i.e. 24 µg l-1). 
In many environmental samples such as landfill leachates, sewage sludge, compost 
water, and some surface waters close to local discharge spots, BPA concentration 
from micro- to milligrams per liter have been reported (Fromme et al. 2002, Wang G. et 
al. 2012, Yamamoto et al. 2001, Svenson et al. 2009, Kamata et al. 2011, Yamada et 
al. 1999, Belfroid et al. 2002, Kolpin et al. 2002). However, in most environmental and 
waste water samples only low BPA concentrations ranging from nanograms up to few 
micrograms per liter have been measured (Bono-Blay et al. 2012, Vethaak et al. 2005, 
Fernandez et al. 2009, Deblonde et al. 2011, Melcer & Klečka 2011, Wang G: et al. 
2012, Arditsoglou & Voutsa 2008, Terasaki et al. 2007). Thus, it is probable that when 
measuring water samples, some sample concentration is needed to reach the LOD of 
the BPA-R bioreporter.  
To show the applicability of the BPA-R bioreporter, influent and effluent waste water 
samples were spiked with BPA and E2, and measured with the BPA-R and hERα 
bioreporters. The BPA-R bioreporter detected only BPA in spiked waste water 
samples, and the response on the sample spiked with both BPA and E2 was similar 
within variations to the sample spiked with BPA only. The BPA measurements of the 
hERα bioreporter, in turn, detected an excess of BPA due to background estrogenicity 
in the waste water. 
In this study, the detected concentrations of BPA and E2 were 30-50% of the 
expected spiked concentrations. Possible reasons for these rather low detection 
efficiencies were assessed. Bioreporter assays have been reported to suffer from 
matrix effect, i.e. reduced recovery, when measuring waste water samples (Salste et 
al. 2007, Balsiger et al. 2010, Mispagel et al. 2009). Chemical analysis methods have 
also been reported to exhibit some matrix effect, although the effect is lower (Wille et 
al. 2012).  
Another factor that could affect detection efficiencies is sample preparation. Freeze 
drying was used in this study to concentrate waste water samples. Freeze drying has 
been considered a good option for water sample concentration because of minimal 
sample activity loss (Salste et al. 2007). In this study, however, freeze drying reduced 
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the detected E2 concentrations of hERα bioreporter by 37%, and BPA detection of 
BPA-R by 31%. It has been suggested that hydrophobic compounds, such as steroid 
hormones, could get adsorbed to the walls of plastic containers during freeze drying 
(Balsiger et al. 2010). Anyhow, freeze drying was considered a reasonably good 
method for concentrating waste water samples. 
As a general conclusion, factors influencing the detection efficiency such as sample 
concentration or bioavailability, should be taken into account. The effects should be 
tested, preferably separately for each compound, by, for example, using control 
samples spiked with a known concentration of each compound of interest. 
BPA-R bioreporter had several other advantages compared to hERα bioreporter, 
such as lower background, higher maximal luminescence level, and lower variation. 
The BPA-R yeast, however, was growing somewhat slower compared to the wild type 
hERα bioreporter. This made parallel analysis using both bioreporters and the toxicity 
control stain challenging because of difficulties in synchronizing their growth. The slow 
growth of BPA-R bioreporter could be due to inefficient mutated codons in the mutant 
receptor P4E C8 (I). Optimization of these codons for more efficient expression in 
yeast could improve growth rate by facilitating the production of the receptor. 
 
4.3. High-throughput yeast bioreporter assays (III) 
The yeast bioreporter assays utilizing receptors hERα, hERβ, hAR, and hAhR were 
miniaturized into high throughput 384 and 1536-well plate formats. Performance of the 
miniaturized bioreporter assays versus the original 96-well plate assays was evaluated 
by comparing the detection limits (LODs) obtained with the reference compound of 
each bioreporter. In addition to LODs, the assay quality was evaluated in each format 
by using Z-factor. Z-factor is a measure of the quality and suitability of an assay to high 
throughput screening (HTS) (Zhang 1999). It shows how well a signal is separated 
from background by taking into account the background and maximal signal levels (i.e. 
the dynamic range of an assay) and the data variability (i.e. the standard deviation). 
According to Zhang et al. (1999), an assay with a Z-factor of 0.5-1 (1 is maximum) is 
excellent for HTS. 
All bioreporter assays had a Z-factor of 0.5 or higher, except for the hERβ in 1536-
well plate format in which the Z-factor was below 0. The reason for the low z-factor of 
hERβ bioreporter in 1536-well plate assay was the low maximal signal level and high 
variation. Overall, the variation was somewhat higher in the miniaturized assay 
formats, probably due to variation of cell number in the low volumes. It seems that 
assays that have high signal-to-background ratio in 96-well plates are best suitable for 
miniaturization to low volume 384 and 1536 well plate formats since they have highest 
probability to retain a good Z-factor. 
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Miniaturization had varying effect on the LODs of the bioreporters. In many cases 
the lowest LODs were in the miniaturized formats whereas in others the 96-well format 
was the most sensitive. In another study with yeast-based NR bioreporter, the tested 
chemicals showed always highest potencies in 96-well plate format, especially at low 
compound concentrations (Berg et al. 2000). In our study (III), however, most of the 
bioreporters appeared to benefit somewhat of miniaturization in respect to LODs. 
The 384 and 1536-well formats required some adjustments to the yeast bioreporter 
assays. Because the luciferase substrate D-luciferin is light and oxygen-sensitive, the 
substrate was previously dispensed on the plates just before measurement by the 
plate reader. However, standard plate readers are usually restricted to dispensing only 
well plates of up to 96 wells. For this reason the D-luciferin substrate was dispensed to 
the 384 and 1536-well plates as a mixture with the yeast culture already before the 
incubation step. Since all previously published cell-based assays using luminescent 
reporter have added the substrate after incubation (Leskinen et al. 2005, Almeida et al. 
2008, Maffia 1999), the survival of the luminescence signal during incubation was 
assessed using the constitutively luminescent BMA64/luc control strain in the presence 
of different D-luciferin concentrations. Of the tested concentrations, 0.5 mM D-luciferin 
was considered most optimal since the signal did not decline during the 4.5 hour 
measurement, and the variation of the signal was low.  
Incubation time was optimized for the miniaturized assays using the hERα 
bioreporter. The most suitable tested incubation time was only 30 min longer for the 
384-well format assays compared to the 96-well format assays, whereas the 1536-well 
format assay was found to benefit from longer incubation of up to 4.5 hours. Probably 
in this format, cell number is critical to obtain a high enough signal. 
In conclusion, miniaturization of the yeast bioreporter assays was successful 
according to the magic triangle of HTS (Mayr & Bojanic 2009): (i) need of reagents and 
consumables became lower, (ii) the assay time was shortened due to automated liquid 
handling and exclusion of substrate addition step, and (iii) good data quality was 
retained. The yeast assays in our research are nowadays routinely performed in 384-
well formats. 
The variability of the miniaturized assays could be lowered by further optimizing the 
automated pipetting techniques. Since the signal intensity of luminescent yeasts is not 
as high as, for example, those of luminescent bacteria, the number of yeast cells 
should be kept as high as possible in miniaturized formats. This could be achieved by 
longer pre-growth, concentration yeast suspension, or using readily suspended freeze-
dried yeast. Freeze-dried yeasts could also simplify the assay and shorten the time 
needed for cultivations. 
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4.4. Tributyl tin yeast bioreporter (IV) 
In this study, a yeast bioreporter for measuring organotin compounds was 
developed and characterized. The bioreporter is the first retinoid X receptor-based 
yeast bioreporter characterized for environmental analysis of organotin compounds. 
None of the other published RXR yeast bioreporters has been used for detection of 
organotin compounds in the environment. A bacterial bioreporter has been developed 
for this purpose (Durand et al. 2003), however, it does not utilize NRs, and the 
mechanism of induction is unknown. In addition, TBT, which is together with TPT the 
most biologically active organotin compound was less potent than dibutyl tin (DBT), 
while TPT showed no potency at all. It is possible that different forms of organotin 
compounds have different impact on bacteria than on eukaryotic organisms. 
In this study, DNA-binding domain (DBD) of human retinoid X receptor α (RXR) was 
replaced with the DBD of hERα to enable the use of the reporter strain BMAEREluc 
which has firefly luciferase reporter gene under control of estrogen receptor-responsive 
elements (ERE). Heery et al. (1993) have constructed a similar chimeric receptor with 
hER DBD but using mouse RXRγ. However, this receptor was not applied for 
environmental studies. 
The responses of the RXR-ER bioreporter on different organotin and retinoic acid 
compounds after 4 hours incubation are shown in Figure 7. Tributyl tin (TBT) and 
triphenyl tin (TPT) were found to be the most potent of the tested chemicals, with LODs 
of 88 nM and 170 nM, respectively. The LOD of the RXR natural ligand 9-cis-retinoic 
acid (9cRA) was even slightly higher, 260 nM. TBT has also previously been reported 
to be more potent than 9cRA in RXR yeast bioreporter (Nishikawa et al. 2004). 
Nishikawa et al. (2004) developed a RXR-based bioreporter that used β-
galactosidase as a reporter. Compared to our RXR-ER bioreporter, this previous one 
was more sensitive towards TBT. However, due to the need for cell lysis for β-
galactosidase assay, this bioreporter is less suitable for HTS formats. 
All-trans retinoic acid (atRA) activated the receptor in this study, although other 
studies (Heery et al. 1993 and 1994, Hall et al. 1993, Li et al. 2008b) have not detected 
any activity of this compound on the RXR receptor. Concentrations of atRA tested in 
this study, however, were higher compared to other studies (Heery et al. 1994, Li et al. 
2008b).  
The dose-response curve of RXR-ER bioreporter towards TBT reached plateau at 
about 1 μM (Figure 7). At 10 μM the dose-response curve started falling even though 
the inductions were corrected for toxicity using the constitutive control strain 
BMA64/luc. 
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Figure 7. RXR-ER bioreporter dose-response curves of organotin and retinoic acid 
compounds. Values represent the mean ± standard deviation of three independent 
experiments, each comprising four parallel data points. 
The control strain showed some concentration-dependent toxicity, expressed as 
correction factor, with TBT and TPT (Figure 8). Surprisingly, the control strain showed 
very little toxicity in the highest tested concentration of 50 µM (Figure 8). This suggests 
that yeast might have some form of resistance mechanism towards organotins that is 
induced at high concentrations. Such would be, for example, an efflux pump, which 
would lower the concentration of organotins in the cell and thus lower the response of 
the bioreporter. An efflux-pump-based resistance mechanism has been shown to lower 
the sensitivity of heavy metal bacterial bioreporters (Hynninen et al. 2010). Removing 
some efflux pumps from the RXR-ER bioreporter could thus improve its sensitivity. 
 
Figure 8. Correction factors obtained by the control yeast strain BMA64/luc with tributyl 
tin (TBT) and triphenyl tin (TPT). Correction factor = signal of blank sample / signal of 
chemical sample. Values represent the mean ± standard deviation of three 
independent experiments, each comprising four parallel data points. 
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TBT has been suspected to be toxic also in bacterial bioreporters. (Durand et al. 
2003). The bacterial bioreporter seems to be more sensitive towards TBT than yeast 
since the dose-response curve started falling already at concentrations higher than 1 
uM. 
The RXR-ER bioreporter was applied in 384-well plate format. In addition, 
sediments spiked with TBT were measured in 96-well plate format. Since the detection 
limit in sediment measurements was at µg TBT per g of sediment, direct measurement 
of sediments require relatively high rate of organotin contamination. The success of 
organotin measurement in natural sediment samples depends also on factors such as 
pH and the organic matter content of the sediment. For example, organic matter might 
reduce bioavailability of organotins (Rüdel 2003).  
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5. CONCLUSIONS AND FUTURE PROSPECTS 
Yeast-based nuclear receptor bioreporters are useful tools for cost-efficient 
chemical testing and environmental monitoring of endocrine disrupting compounds. 
They are easy to handle and they require no special laboratory conditions, instruments 
or experienced users. 
In this thesis study the battery of existing yeast nuclear receptor bioassays using 
firefly luciferase reporter was expanded with two new bioreporters: the bisphenol A-
targeted BPA-R and organotin RXR-ER bioreporter strains. 
The BPA-R bioreporter enables specific analysis of BPA in environmental and other 
complex samples. It is well suitable for high throughput screening of large number of 
samples. BPA exposure and possible sources are a continuous topic of studies even 
today. The BPA-R bioreporter offers a new tool for assessing exposure of humans and 
wildlife as well as monitoring possible sources and environmental levels. Possible 
application could include, for example measuring BPA in food, and environmental or 
waste water samples, or monitoring BPA leakage from water pipes lined with epoxy 
resin. BPA-R bioreporter has been planned to be used in direct analysis of BPA in 
thermal paper. Another interesting application could be to monitor environmental BPA 
sources, such as landfill effluents. 
On the course creating the BPA-R bioreporter, a mutation and selection method for 
hERα was applied. Using this method, the ligand-binding properties of hERα was 
modified by only one round of mutation, and the library was efficiently selected against 
both positive and negative ligand activities. Possible further applications of this method 
could be improving the sensitivities of existing bioreporters BPA-R and RXR-ER, which 
still have somewhat high detection limits. In addition, receptors with targeted affinities 
to other interesting chemicals could be accomplished, creating more tools for 
bioreporter-based specific detection of chemicals. 
Although popular and promising, the yeast NR bioreporter assays have suffered 
from lack of development towards truly high throughput screening formats. In this 
thesis study the applicability of yeast NR bioassays for robotic liquid handling and high 
density 384 and 1536-well plates were evaluated. Nearly all assays were readily 
applied to both formats, reducing the need of material, sample, and reagents as well as 
assay time. At present, all our yeast assays are routinely performed in 384-well plate 
format, enabling analysis of high number of samples. Furthermore, all assays can be 
performed during only one working day. 
Future improvement in the yeast bioreporter assays could be minimizing need for 
cultivations by using freeze dried cells. The existing yeast bioreporter assays could 
also be evaluated by subjecting them to international validation in measuring large 
numbers of some complex samples, or screening a whole compound library. 
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